CL · XBRL financial data

Colgate-Palmolive Company financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (CL's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	16,471	17,421	17,967	19,457	20,101	20,382
Cost of revenue	6,454	7,046	7,719	8,131	7,940	8,131
Gross profit	10,017	10,375	10,248	11,326	12,161	12,251
Research and development	290	307	320	343	355	366
Selling, general and administrative	6,019	6,407	6,565	7,151	7,729	7,903
Other operating income (expense)	(113)	(65)	(69)	(191)	(164)	(123)
Operating income (loss)	3,885	3,332	2,893	3,984	4,268	3,306
Interest income	—	—	14	55	67	75
Interest expense	184	195	167	287	292	267
Income tax expense (benefit)	787	749	693	937	907	798
Net income (loss)	2,695	2,166	1,785	2,300	2,889	2,132
Earnings per share, basic USD per share	3.15	2.56	2.13	2.78	3.53	2.64
Earnings per share, diluted USD per share	3.14	2.55	2.13	2.77	3.51	2.63
Weighted average shares, basic millions of shares	857	845	836	827	819	809
Weighted average shares, diluted millions of shares	859	848	839	829	823	811

Fiscal years (CL's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	888	832	775	966	1,096	1,288
Marketable securities	—	—	—	179	160	107
Accounts receivable	1,264	1,297	1,504	1,586	1,521	1,675
Inventory	1,673	1,692	2,074	1,934	1,987	2,032
Total current assets	4,338	4,397	5,113	5,279	5,317	5,709
Property and equipment, net	3,716	3,730	4,307	4,582	4,422	4,660
Right-of-use asset	521	527	478	491	529	531
Goodwill	3,824	3,284	3,352	3,410	3,272	3,122
Total assets	15,920	15,040	15,731	16,393	16,046	16,330
Accounts payable	1,393	1,479	1,551	1,698	1,805	2,089
Current portion of long-term debt	9	12	14	20	652	1,115
Total current liabilities	4,404	4,051	4,004	4,741	5,759	6,853
Long-term debt	7,334	7,194	8,741	8,219	7,289	6,871
Lease liability, non-current	476	451	397	420	456	448
Total liabilities	14,819	14,069	14,925	15,436	15,502	15,965
Retained earnings	23,699	24,350	24,573	25,289	26,145	26,595
Total stockholders' equity	743	609	401	609	212	54
Total liabilities and equity	15,920	15,040	15,731	16,393	16,046	16,330
Common shares outstanding (cover page) millions of shares	849	840	830	823	812	802

Fiscal years (CL's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	2,695	2,166	1,785	2,300	2,889	2,132
Stock-based compensation	107	135	125	122	135	155
Depreciation and amortization	539	556	545	567	605	630
Net cash from operating activities	3,719	3,325	2,556	3,745	4,107	4,198
Purchases of property and equipment	409	567	696	—	—	—
Net cash from investing activities	(779)	(592)	(1,601)	(742)	(534)	(817)
Share repurchases	1,476	1,320	1,308	1,128	1,739	1,210
Net cash from financing activities	(2,919)	(2,774)	(952)	(2,793)	(3,389)	(3,256)
Net change in cash	5	(56)	(57)	191	130	192

SIC 2844 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2844 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
Colgate Palmolive	1,527	5,369	1,171*	794.9M	Q3 FY26 10-QSep 30, 2026
Ecolab	722	4,695	764*	280.5M	Q3 FY26 10-QSep 30, 2026
Kenvue	1,039	3,886	700*	1.9B	Q3 FY26 10-QSep 27, 2026
Estee Lauder Companies	3,198	3,715	(166)	not reported	Q1 FY27 10-QSep 30, 2026
Church & Dwight	447	1,602	380*	236.0M	Q3 FY26 10-QSep 30, 2026
Clorox	184	1,905	143	121.1M	Q1 FY27 10-QSep 30, 2026
Procter & Gamble	15,365	23,276	5,767	2.3B	Q1 FY27 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.